Susquehanna International Group, LLP Myriad Genetics Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $174,981 - $208,780	-7,300 Reduced 31.47%	15,900 $435,000
Q2 2024 Aug 15, 2024	BUY	$17.98 - $25.47 $417,136 - $590,904	23,200 New	23,200 $567,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $331,422 - $507,416	18,200 Added 102.82%	35,900 $685,000
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $70,735 - $111,284	4,300 Added 32.09%	17,700 $322,000
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $161,671 - $218,621	-6,700 Reduced 33.33%	13,400 $370,000
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $2,997 - $3,665	-100 Reduced 0.5%	20,100 $649,000
Q2 2021 Aug 11, 2021	SELL	$25.39 - $32.61 $55,858 - $71,742	-2,200 Reduced 9.82%	20,200 $618,000
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $157,368 - $249,640	-7,900 Reduced 26.07%	22,400 $682,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $58,368 - $94,896	-4,800 Reduced 13.68%	30,300 $599,000
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $174,375 - $228,625	-15,500 Reduced 30.63%	35,100 $458,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $73,761 - $113,780	-6,900 Reduced 12.0%	50,600 $574,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $88,020 - $265,770	-9,000 Reduced 13.53%	57,500 $823,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $912,548 - $1.53 Million	-43,600 Reduced 39.6%	66,500 $1.81 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $366,528 - $781,528	16,600 Added 17.75%	110,100 $3.15 Million
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $102,015 - $157,500	-4,500 Reduced 4.59%	93,500 $2.6 Million
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $1.98 Million - $2.55 Million	73,600 Added 301.64%	98,000 $3.25 Million
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $707,980 - $1.18 Million	-26,000 Reduced 51.59%	24,400 $709,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $841,568 - $1.13 Million	-22,400 Reduced 30.77%	50,400 $2.32 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $357,975 - $518,193	-12,900 Reduced 15.05%	72,800 $2.72 Million
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $1.23 Million - $1.75 Million	42,600 Added 98.84%	85,700 $2.53 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $1.35 Million - $1.76 Million	-47,500 Reduced 52.43%	43,100 $1.48 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $2.18 Million - $3.28 Million	90,600	90,600 $3.28 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$232 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$158 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$103 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$79.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$72 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account